Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$16,444,940
-$23,170,006 QoQ
Shares Held
104,932
-59.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#131
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 83%
Shared 0%
None 17%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BANK OF MONTREAL /CAN/ holds $6,780,882,947 across 16 Drug Manufacturers - General names. NVS ranks #13 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,724,702 | $2,068,659,488 | |
| 2 | JNJ |
Johnson & Johnson
|
4,646,972 | $1,180,191,474 | |
| 3 | ABBV |
AbbVie Inc.
|
3,470,007 | $873,192,557 | |
| 4 | MRK |
Merck & Co., Inc.
|
5,565,728 | $715,196,045 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
3,772,428 | $476,608,548 | |
| 6 | AZN |
Astrazeneca PLC
|
2,359,807 | $447,466,599 | |
| 7 | AMGN |
Amgen Inc
|
882,230 | $319,473,122 | |
| 8 | GSK |
GSK plc
|
4,042,863 | $211,926,875 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,444,940 | 104,932 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $39,614,946 | 259,345 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $135,746,661 | 984,599 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $134,035,290 | 1,045,191 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $68,369,436 | 564,990 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $10,692,043 | 95,910 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $52,577,758 | 540,312 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $89,828,316 | 780,980 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $70,040,351 | 657,903 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $14,348,539 | 148,336 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $14,684,570 | 145,435 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $15,515,109 | 152,318 | Shares | Defined | 2023-11-01 | |
| 2023-06-30 | $15,332,263 | 151,940 | Shares | Defined | 2023-08-02 | |
| 2023-03-31 | $14,365,156 | 156,143 | Shares | Defined | 2024-06-13 | |
| 2022-12-31 | $14,464,394 | 159,440 | Shares | Defined | 2023-02-01 | |
| 2022-09-30 | $17,071,160 | 224,591 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $13,379,237 | 158,278 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $14,559,566 | 165,921 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $22,886,960 | 261,655 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $15,864,826 | 193,994 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $33,308,894 | 365,069 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $14,577,073 | 170,532 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $14,056,280 | 148,854 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $13,007,038 | 149,575 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $12,858,279 | 147,221 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $12,397,426 | 150,363 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||